Literature DB >> 25948622

Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.

Jeffery D Haines1, Oscar G Vidaurre1, Fan Zhang1, Ángela L Riffo-Campos2, Josefa Castillo2, Bonaventura Casanova3, Patrizia Casaccia4, Gerardo Lopez-Rodas5.   

Abstract

BACKGROUND: Cerebrospinal fluid (CSF) is in contact with brain parenchyma and ventricles, and its composition might influence the cellular physiology of oligodendrocyte progenitor cells (OPCs) thereby contributing to multiple sclerosis (MS) disease pathogenesis.
OBJECTIVE: To identify the transcriptional changes that distinguish the transcriptional response induced in proliferating rat OPCs upon exposure to CSF from primary progressive multiple sclerosis (PPMS) or relapsing remitting multiple sclerosis (RRMS) patients and other neurological controls.
METHODS: We performed gene microarray analysis of OPCs exposed to CSF from neurological controls, or definitive RRMS or PPMS disease course. Results were confirmed by quantitative reverse transcriptase polymerase chain reaction, immunocytochemistry and western blot of cultured cells, and validated in human brain specimens.
RESULTS: We identified common and unique oligodendrocyte genes for each treatment group. Exposure to CSF from PPMS uniquely induced branching of cultured progenitors and related transcriptional changes, including upregulation (P<0.05) of the adhesion molecule GALECTIN-3/Lgals3, which was also detected at the protein level in brain specimens from PPMS patients. This pattern of gene expression was distinct from the transcriptional programme of oligodendrocyte differentiation during development.
CONCLUSIONS: Despite evidence of morphological differentiation induced by exposure to CSF of PPMS patients, the overall transcriptional response elicited in cultured OPCs was consistent with the activation of an aberrant transcriptional programme.
© The Author(s), 2015.

Entities:  

Keywords:  Cerebrospinal fluid; differentiation; gene expression; oligodendrocyte progenitor cells

Mesh:

Substances:

Year:  2015        PMID: 25948622      PMCID: PMC4628566          DOI: 10.1177/1352458515573094

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  30 in total

1.  Differential microRNA expression in blood in multiple sclerosis.

Authors:  Helle Bach Søndergaard; Dan Hesse; Martin Krakauer; Per Soelberg Sørensen; Finn Sellebjerg
Journal:  Mult Scler       Date:  2013-06-17       Impact factor: 6.312

Review 2.  Pathophysiology of the brain extracellular matrix: a new target for remyelination.

Authors:  Lorraine W Lau; Rowena Cua; Michael B Keough; Sarah Haylock-Jacobs; V Wee Yong
Journal:  Nat Rev Neurosci       Date:  2013-08-29       Impact factor: 34.870

3.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function.

Authors:  L A Pasquini; V Millet; H C Hoyos; J P Giannoni; D O Croci; M Marder; F T Liu; G A Rabinovich; J M Pasquini
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

4.  Axonal damage in multiple sclerosis.

Authors:  Jeffery D Haines; Matilde Inglese; Patrizia Casaccia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 5.  Multiple sclerosis - remyelination failure as a cause of disease progression.

Authors:  Karin Hagemeier; Wolfgang Brück; Tanja Kuhlmann
Journal:  Histol Histopathol       Date:  2012-03       Impact factor: 2.303

6.  Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Authors:  C E Teunissen; M J A Koel-Simmelink; T V Pham; J C Knol; M Khalil; A Trentini; J Killestein; J Nielsen; H Vrenken; V Popescu; C D Dijkstra; C R Jimenez
Journal:  Mult Scler       Date:  2011-04-19       Impact factor: 6.312

7.  Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.

Authors:  M Cristofanilli; B Cymring; A Lu; H Rosenthal; S A Sadiq
Journal:  Neuroscience       Date:  2013-07-19       Impact factor: 3.590

8.  Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.

Authors:  Chiara Fenoglio; Elisa Ridolfi; Claudia Cantoni; Milena De Riz; Rossana Bonsi; Maria Serpente; Chiara Villa; Anna M Pietroboni; Robert T Naismith; Enrique Alvarez; Becky J Parks; Nereo Bresolin; Anne H Cross; Laura M Piccio; Daniela Galimberti; Elio Scarpini
Journal:  Mult Scler       Date:  2013-12       Impact factor: 6.312

9.  Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.

Authors:  Jimmy L Huynh; Paras Garg; Tin Htwe Thin; Seungyeul Yoo; Ranjan Dutta; Bruce D Trapp; Vahram Haroutunian; Jun Zhu; Michael J Donovan; Andrew J Sharp; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2013-11-24       Impact factor: 24.884

10.  Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy.

Authors:  Julie Hoover-Fong; Nara Sobreira; Julie Jurgens; Peggy Modaff; Carrie Blout; Ann Moser; Ok-Hwa Kim; Tae-Joon Cho; Sung Yoon Cho; Sang Jin Kim; Dong-Kyu Jin; Hiroshi Kitoh; Woong-Yang Park; Hua Ling; Kurt N Hetrick; Kimberly F Doheny; David Valle; Richard M Pauli
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

View more
  7 in total

1.  Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients.

Authors:  Deepali Mathur; Angela L Riffo-Campos; Josefa Castillo; Jeffery D Haines; Oscar G Vidaurre; Fan Zhang; Francisco Coret-Ferrer; Patrizia Casaccia; Bonaventura Casanova; Gerardo Lopez-Rodas
Journal:  Front Cell Neurosci       Date:  2017-07-18       Impact factor: 5.505

Review 2.  Cerebrospinal fluid-stem cell interactions may pave the path for cell-based therapy in neurological diseases.

Authors:  Chao Ren; Peiyuan Yin; Neng Ren; Zhe Wang; Jiahui Wang; Caiyi Zhang; Wei Ge; Deqin Geng; Xiaotong Wang
Journal:  Stem Cell Res Ther       Date:  2018-03-09       Impact factor: 6.832

3.  Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course.

Authors:  Kamilah Castro; Achilles Ntranos; Mario Amatruda; Maria Petracca; Peter Kosa; Emily Y Chen; Johannes Morstein; Dirk Trauner; Corey T Watson; Michael A Kiebish; Bibiana Bielekova; Matilde Inglese; Ilana Katz Sand; Patrizia Casaccia
Journal:  EBioMedicine       Date:  2019-04-10       Impact factor: 8.143

Review 4.  Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases.

Authors:  Luana C Soares; Osama Al-Dalahmah; James Hillis; Christopher C Young; Isaiah Asbed; Masanori Sakaguchi; Eric O'Neill; Francis G Szele
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

5.  Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.

Authors:  Omri Zveik; Nina Fainstein; Ariel Rechtman; Nitzan Haham; Tal Ganz; Iris Lavon; Livnat Brill; Adi Vaknin-Dembinsky
Journal:  Glia       Date:  2022-03-09       Impact factor: 8.073

Review 6.  Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.

Authors:  Juan García-Revilla; Antonio Boza-Serrano; Ana M Espinosa-Oliva; Manuel Sarmiento Soto; Tomas Deierborg; Rocío Ruiz; Rocío M de Pablos; Miguel Angel Burguillos; Jose L Venero
Journal:  Cell Death Dis       Date:  2022-07-20       Impact factor: 9.685

Review 7.  Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination.

Authors:  Laura Thomas; Laura Andrea Pasquini
Journal:  Front Cell Neurosci       Date:  2018-09-12       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.